Bml Capital Management, LLC Forte Biosciences, Inc. Transaction History

Bml Capital Management, LLC

  • $170 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 23, 2023
BUY
$0.65 - $1.04 $17,307 - $27,692
26,627 Added 1.53%
1,761,702 $1.17 Billion
Q1 2023

Apr 14, 2023
BUY
$0.98 - $1.06 $268,236 - $290,133
273,711 Added 18.73%
1,735,075 $1.75 Billion
Q4 2022

Feb 13, 2023
BUY
$0.96 - $28.0 $1.4 Million - $40.9 Million
1,461,364 New
1,461,364 $1.46 Billion

Others Institutions Holding FBRX

# of Institutions
1
Shares Held
175K
Call Options Held
0
Put Options Held
0
View Full List

About Forte Biosciences, Inc.

FBRX Quotes by TradingView
  • Ticker FBRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 20,340,300
  • Market Cap $114M
  • Description
  • Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. It is developing FB-102 program that addresses various autoimmune diseases, such as vitiligo and alopecia areata. The company is headquartered in Dallas, Texas.
More about FBRX
Track This Portfolio

Track Bml Capital Management, LLC Portfolio

Follow Bml Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bml Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bml Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email